18889881171
Kalkine 0
countryflagUS
Login

AAPL 179.46 -1.1022% MSFT 361.16 0.9221% NVDA 99.8699 2.2838% GOOGL 147.7072 0.6523% GOOG 149.84 0.402% AMZN 175.8608 0.3428% META 519.62 0.6528% AVGO 161.55 4.8073% LLY 733.0192 1.2835% TSLA 232.8325 -0.1961% TSM 145.8853 -0.1948% V 317.355 1.6121% JPM 221.4275 3.2585% UNH 554.49 5.6775% NVO 62.055 -2.4906% WMT 84.375 0.6501% LVMUY 112.12 0.7186% XOM 103.0 0.0583% LVMHF 563.0 0.8961% MA 490.7 1.0669%
AAPL 179.46 -1.1022% MSFT 361.16 0.9221% NVDA 99.8699 2.2838% GOOGL 147.7072 0.6523% GOOG 149.84 0.402% AMZN 175.8608 0.3428% META 519.62 0.6528% AVGO 161.55 4.8073% LLY 733.0192 1.2835% TSLA 232.8325 -0.1961% TSM 145.8853 -0.1948% V 317.355 1.6121% JPM 221.4275 3.2585% UNH 554.49 5.6775% NVO 62.055 -2.4906% WMT 84.375 0.6501% LVMUY 112.12 0.7186% XOM 103.0 0.0583% LVMHF 563.0 0.8961% MA 490.7 1.0669%

Canopy Growth Corp

Healthcare US CGC

0.86USD
-0.0705(7.58%)

Last update at 2025-04-08T16:52:00Z

Day Range

0.840.98
LowHigh

52 Week Range

2.7519.20
LowHigh

Fundamentals

  • Previous Close 0.93
  • Market Cap637.48M
  • Volume3388782
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-245.69600M
  • Revenue TTM362.24M
  • Revenue Per Share TTM5.59
  • Gross Profit TTM -81.93800M
  • Diluted EPS TTM-14.34

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

2019-03-312020-03-312021-03-312022-03-312023-03-31-3000M-2500M-2000M-1500M-1000M-500M0M500M
Total Revenue
Net Income

Balancesheet

2019-03-312020-03-312021-03-312022-03-312023-03-310M1000M2000M3000M4000M5000M6000M7000M8000M
Total Assets
Total Liabilities

Change in Cash

2019-03-312020-03-312021-03-312022-03-312023-03-31-1000M-500M0M500M1000M1500M2000M

Total Operating Cash

2019-03-312020-03-312021-03-312022-03-312023-03-31-800M-750M-700M-650M-600M-550M-500M-450M

Dividends Paid

2019-03-312020-03-312021-03-312022-03-312023-03-310M
Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Income before tax -3314.32000M -329.43300M -1683.96100M -1509.05400M -657.77600M
Minority interest 31.39M 18.30M 140.01M 291.51M 291.88M
Net income -3309.54600M -320.48500M -1670.82000M -1387.44000M -670.09400M
Selling general administrative 487.41M 520.28M 666.54M 624.91M 451.44M
Selling and marketing expenses 243.45M 239.28M 194.40M 242.83M 154.39M
Gross profit -104.14000M -193.05400M 66.96M -31.68400M 88.93M
Reconciled depreciation 84.52M 114.42M 127.12M 125.01M 46.92M
Ebit 1665.19M -1082.67400M 44.30M -1668.96300M -553.64500M
Ebitda 1749.71M -229.57800M 171.42M -1357.22600M -483.33300M
Depreciation and amortization 84.52M 853.10M 127.12M 311.74M 70.31M
Non operating income net other - - - - 0.00000M
Operating income 1665.19M -1082.67400M 44.30M -1668.96300M -553.64500M
Other operating expenses 994.46M 1233.66M 1146.23M 1423.63M 779.99M
Interest expense 126.16M 103.94M 8.46M 6.72M 18.41M
Tax provision -4.77400M -8.94800M -13.14100M -121.61400M 4.11M
Interest income 24.28M 6.60M 21.37M 84.68M 88.75M
Net interest income -101.87800M -97.34300M 12.91M 59.61M 30.90M
Extraordinary items - - - - 0.00000M
Non recurring - - - - 0.00000M
Other items - - - - 0.00000M
Income tax expense -4.77400M -8.94800M -13.14100M -121.61400M 12.32M
Total revenue 402.90M 520.33M 546.65M 398.77M 226.34M
Total operating expenses 487.41M 520.28M 666.54M 993.17M 642.58M
Cost of revenue 507.04M 713.38M 479.69M 430.46M 137.41M
Total other income expense net -4979.50900M 753.24M -1728.26100M 159.91M -104.13100M
Discontinued operations - - - - 0.00000M
Net income from continuing ops -3309.54600M -320.48500M -1670.82000M -1387.44000M -670.09400M
Net income applicable to common shares - -302.18100M -1744.92000M -1321.32600M -736.28100M
Preferred stock and other adjustments - - - - 0.00000M
Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Total assets 2439.10M 5615.05M 6823.48M 6857.74M 8731.81M
Intangible assets 188.72M 252.69M 308.17M 476.37M 519.56M
Earning assets - - - - -
Other current assets 10.12M 19.07M 67.23M 14.68M 78.97M
Total liab 1679.08M 1984.55M 3201.66M 1679.88M 1490.36M
Total stockholder equity 758.43M 3589.96M 3481.81M 4886.36M 6951.63M
Deferred long term liab - - - - 0.00000M
Other current liab 94.73M 139.33M 106.43M 199.35M 81.41M
Common stock 7938.57M 7482.81M 7168.56M 6373.54M 6026.62M
Capital stock 7938.57M 7482.81M 7168.56M 6373.54M 6026.62M
Retained earnings -9672.76100M -6370.33700M -6068.15600M -4323.23600M -777.08700M
Other liab - 89.91M 1250.03M 690.22M 239.09M
Good will 85.56M 1866.50M 1889.35M 1954.47M 1544.06M
Other assets - 15.34M 4.96M 22.64M 25.90M
Cash 677.01M 776.00M 1154.65M 1303.18M 2480.83M
Cash and equivalents - - - - -
Total current liabilities 803.84M 212.90M 284.33M 420.59M 411.66M
Current deferred revenue 75.99M - 100.81M 41.09M 37.61M
Net debt 629.87M 724.99M 428.31M -677.35800M -1534.85500M
Short term debt 556.89M 9.30M 9.83M 56.75M 103.72M
Short long term debt 556.89M 9.30M 9.83M 16.39M 103.72M
Short long term debt total 1306.88M 1500.99M 1582.96M 625.82M 945.98M
Other stockholder equity -7166.27600M 2519.77M 2415.65M 2615.16M 2037.25M
Property plant equipment - 942.78M 1074.54M 1524.80M 1096.34M
Total current assets 1077.25M 1737.40M 2838.19M 2564.37M 5070.14M
Long term investments 568.29M 341.73M 708.27M 315.10M 475.81M
Net tangible assets - 1470.76M 1284.29M 2455.53M 4732.29M
Short term investments 105.59M 595.65M 1144.56M 673.32M 2034.13M
Net receivables 93.99M 96.44M 92.44M 90.16M 106.97M
Long term debt 749.99M 1491.69M 1573.14M 449.02M 842.26M
Inventory 148.90M 204.39M 367.98M 391.09M 262.11M
Accounts payable 76.23M 64.27M 67.26M 123.39M 188.92M
Total permanent equity - - - - 0.00000M
Noncontrolling interest in consolidated entity - - - - 0.00000M
Temporary equity redeemable noncontrolling interests - - - - 0.00000M
Accumulated other comprehensive income -13.86000M -42.28200M -34.24000M 220.90M 1702.10M
Additional paid in capital - - - - 0.00000M
Common stock total equity - - 7168.56M 6373.54M 6026.62M
Preferred stock total equity - - - - 0.00000M
Retained earnings total equity - - - - 0.00000M
Treasury stock - - - - 0.00000M
Accumulated amortization - - - - 0.00000M
Non currrent assets other 19.45M -0.64900M -16.41800M -24.47700M 25.90M
Deferred long term asset charges - - - - 0.00000M
Non current assets total 1361.84M 3877.65M 3985.29M 4293.37M 3661.66M
Capital lease obligations 109.31M 139.16M 136.22M 40.36M 0.00000M
Long term debt total - - - 500.66M 842.26M
Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Investments 433.38M 166.58M -497.55500M 1292.76M -2158.04500M
Change to liabilities - -35.84400M -9.62700M -20.75000M 69.54M
Total cashflows from investing activities - 230.82M -884.10500M -347.65400M -3227.98500M
Net borrowings - -50.76300M 877.54M -100.19200M 595.32M
Total cash from financing activities -19.69400M -45.53300M 1264.77M -57.16100M 5837.20M
Change to operating activities - 24.47M 0.08M -26.91700M -87.47600M
Net income -3309.54600M -320.48500M -1670.82000M -1387.44000M -670.09400M
Change in cash -98.99800M -378.64800M -148.52300M -1177.65400M 2158.27M
Begin period cash flow 776.00M 1154.65M 1303.18M 2480.83M 322.56M
End period cash flow 677.01M 776.00M 1154.65M 1303.18M 2480.83M
Total cash from operating activities -557.54600M -545.81100M -465.72900M -772.63500M -520.51000M
Issuance of capital stock 1.05M 2.70M 1.38M 1.17M 5227.48M
Depreciation 84.52M 114.42M 127.12M 125.01M 46.92M
Other cashflows from investing activities - -18.12600M -66.74600M -419.67200M -419.67200M
Dividends paid - - - - 0.00000M
Change to inventory 55.64M 173.19M 17.21M -177.09100M -144.91700M
Change to account receivables - 3.74M 9.63M 20.75M -67.68800M
Sale purchase of stock - - - 43.03M 5294.43M
Other cashflows from financing activities 97.44M 2.53M 1279.01M 56.62M 614.40M
Change to netincome - -523.60600M 1156.41M 627.46M 384.87M
Capital expenditures 10.55M 48.11M 174.14M 721.90M 682.75M
Change receivables - - - - 0.00000M
Cash flows other operating - - - - 0.00000M
Exchange rate changes - - - - 0.00000M
Cash and cash equivalents changes - - - - 0.00000M
Change in working capital 65.84M 165.56M -4.33300M -203.77900M -262.16800M
Stock based compensation 31.19M 47.52M 91.15M 320.28M 287.78M
Other non cash items 2575.22M -543.87900M 1004.30M 494.91M 64.73M
Free cash flow -568.10000M -593.92400M -639.87000M -1494.53600M -1203.25600M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CGC
Canopy Growth Corp		 -0.0705 7.58% 0.86 - - 1.97 1.79 2.99 -1.059
ZTS
Zoetis Inc		 -2.42 1.62% 146.68 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 0.03 0.12% 24.98 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 - -% 122.45 21.73 14.95 3.16 2.15 3.56 12.82
TAK
Takeda Pharmaceutical Co Ltd ADR		 -0.135 0.94% 14.24 32.67 11.53 0.01 0.87 0.02 0.07

Reports Covered

Stock Research & News

View All

Profile

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

Canopy Growth Corp

1 Hershey Drive, Smiths Falls, ON, Canada, K7A 0A8

Key Executives

Name Title Year Born
Mr. David Eric Klein CEO & Director 1964
Ms. Judy Eunjoo Hong VP of Investor Relations & Competitive Intelligence, Chief of Staff to the CEO and CFO 1973
Mr. Julious C. Grant Jr. Chief Commercial Officer 1968
Mr. Jonathan Di Tosto Chief Operations Officer NA
Mr. Thomas Carlton Stewart VP & Chief Accounting Officer 1982
Mr. Thomas Shipley IV Sr. VP of Quality Assurance & Chief Science Officer 1989
Dr. Christelle Gedeon L.L.B., Ph.D. Chief Legal Officer 1982
Mr. Timothy Rob Saunders F.C.A., FCPA Strategic Advisor 1961
Jason Green Head of Agriculture - Hemp Division NA
Dr. Mark A. Ware Chief Medical Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.